Back to CVE records
Medium 5.4Published Mar 25, 2026

CVE-2026-3591A stack use-after-return flaw in SIG(0) handling code may enable ACL bypass

Updated under an hour ago ()

Does this affect you?

It affects ISC BIND 9 and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A use-after-return vulnerability exists in the `named` server when handling DNS queries signed with SIG(0). Using a specially-crafted DNS request, an attacker may be able to cause an ACL to improperly (mis)match an IP address. In a default-allow ACL (denying only specific IP addresses), this may lead to unauthorized access. Default-deny ACLs should fail-secure. This issue affects BIND 9 versions 9.20.0 through 9.20.20, 9.21.0 through 9.21.19, and 9.20.9-S1 through 9.20.20-S1. BIND 9 versions 9.18.0 through 9.18.46 and 9.18.11-S1 through 9.18.46-S1 are NOT affected.

CVSS
5.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
Weakness (CWE)
CWE-562, CWE-305
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
isc
NVD analysis
Analyzed
Record last updated
Mar 25, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
ISC BIND 9
isc:bind_9 (from the name)
from 9.20.0 through 9.20.20; from 9.21.0 through 9.21.19; from 9.20.9-S1 through 9.20.20-S1; from 9.18.0 through 9.18.46 not affected; from 9.18.11-S1 through 9.18.46-S1 not affected
CNA record
isc bind
isc:bind
from 9.20.0 before 9.20.21; from 9.21.0 before 9.21.20
NVD

References

  • vendor-advisory
  • patch
  • patch

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.